Sohal Amartej Singh, Anand Asha, Kaur Prabhjot, Kaur Harpreet, Attri Joginder Pal
Department of Anaesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India.
Department of SPM, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India.
Anesth Essays Res. 2021 Jan-Mar;15(1):8-13. doi: 10.4103/aer.aer_53_21. Epub 2021 Aug 30.
Acute respiratory failure is a potential complication of chronic obstructive pulmonary disease (COPD) that severely affects the health of the patient and may require mechanical ventilation. We compared noninvasive and invasive mechanical ventilation in COPD patients with acute respiratory failure type II to validate clinical outcome based on biochemical analysis of arterial blood gases (ABGs) and pulmonary parameters in terms of duration of mechanical ventilation, period spent in intensive care unit (ICU) and mortality.
After approval of institutional ethical committee 100 patients were selected for randomized prospective controlled trial and divided into two groups of 50 each according to mode of mechanical ventilation. Group-I patients managed with noninvasive ventilation (NIV) Group-ll managed with invasive ventilation.
Demographic data between two groups were comparable. ABG parameters were better at 2 h and 6 h interval in NIV as compared to invasive ventilation ( < 0.05). The duration of ventilation and total time spent in ICU was 106±10 hours and 168±8 hours respectively in NIV group and 218 ± 12 and 280 ± 20 in invasive group. On intergroup comparison these were significantly less in noninvasive group ( < 0.05). Hospital acquired pneumonia occurred in 10% of patients in invasive group whereas no incidence of pneumonia found in noninvasive group. Mortality rate was 12% in invasive groups and 2% in noninvasive groups.
NIV leads to significant improvement in ABG and pulmonary parameters and it reduces duration of ventilation and total period of hospital stay so it can be used as an alternative to invasive ventilation as first-line treatment in COPD.
急性呼吸衰竭是慢性阻塞性肺疾病(COPD)的一种潜在并发症,严重影响患者健康,可能需要机械通气。我们比较了II型急性呼吸衰竭COPD患者的无创和有创机械通气,以基于动脉血气(ABG)的生化分析和机械通气持续时间、重症监护病房(ICU)住院时间及死亡率等肺部参数来验证临床结局。
经机构伦理委员会批准,选择100例患者进行随机前瞻性对照试验,并根据机械通气模式分为两组,每组50例。I组患者采用无创通气(NIV)治疗,II组采用有创通气治疗。
两组间的人口统计学数据具有可比性。与有创通气相比,NIV组在2小时和6小时间隔时的ABG参数更好(P<0.05)。NIV组的通气持续时间和在ICU的总时间分别为106±10小时和168±8小时,有创组分别为218±12小时和280±20小时。组间比较显示,无创组的这些指标明显更低(P<0.05)。有创组10%的患者发生医院获得性肺炎,而无创组未发现肺炎病例。有创组的死亡率为12%,无创组为2%。
NIV可使ABG和肺部参数显著改善,并缩短通气持续时间和住院总时间,因此可作为COPD一线治疗的有创通气替代方法。